Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3077-27-8

3077-27-8

Post Buying Request

3077-27-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3077-27-8 Usage

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 3077-27-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,7 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3077-27:
(6*3)+(5*0)+(4*7)+(3*7)+(2*2)+(1*7)=78
78 % 10 = 8
So 3077-27-8 is a valid CAS Registry Number.
InChI:InChI=1/C22H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20-23-21(24)18-19-22(25)26/h18-19H,2-17,20H2,1H3,(H,23,24)(H,25,26)/b19-18+

3077-27-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(octadecylamino)-4-oxo-(2Z)-2-Butenoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3077-27-8 SDS

3077-27-8Downstream Products

3077-27-8Relevant articles and documents

Compound, application thereof, platinum coordination complex and liposome thereof

-

Paragraph 0190-0194, (2017/08/31)

The invention relates to the field of medicines, in particular to a compound, application thereof, a platinum coordination complex and liposome thereof. The platinum coordination complex disclosed by the invention can be well combined with a membrane material of the liposome, so that encapsulation efficiency and drug loading capacity of the liposome are improved; furthermore, the platinum coordination complex disclosed by the invention contains carboxyl and has pH sensitivity; the carboxyl trends to be deprotonated in lower pH value environment (such as tumor tissues), so that release of medicine in the tumor tissues is improved, and a curing effect of medicine is improved. Experiments show that the liposome disclosed by the invention can reduce toxic and side effects of the medicine and improve medicine effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3077-27-8